Fragment-based drug design and identification of HJC0123 , a novel orally bioavailable STAT3 inhibitor for cancer therapy - Concepedia

Concepedia

Publication | Open Access

Fragment-based drug design and identification of HJC0123 , a novel orally bioavailable STAT3 inhibitor for cancer therapy

DOI Full Paper Access

94

Citations

25

References

2013

Year

Haijun Chen, Zhengduo Yang, Chunyong Ding, Lili Chu, Yusong Zhang, Kristin Terry, Huiling Liu, Qiang Shen, Jia Zhou

European Journal of Medicinal Chemistry

Cancer TherapyBioavailable Stat3 InhibitorMedicineFragment-based Drug DesignPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyNovel TherapyCancer ResearchDrug Discovery

References

	Year	Citations

Page 1

Page 1